Driving Chromatin Organisation through N6-methyladenosine Modification of RNA: What Do We Know and What Lies Ahead?
- PMID: 35205384
- PMCID: PMC8871937
- DOI: 10.3390/genes13020340
Driving Chromatin Organisation through N6-methyladenosine Modification of RNA: What Do We Know and What Lies Ahead?
Abstract
In recent years, there has been an increase in research efforts surrounding RNA modification thanks to key breakthroughs in NGS-based whole transcriptome mapping methods. More than 100 modifications have been reported in RNAs, and some have been mapped at single-nucleotide resolution in the mammalian transcriptome. This has opened new research avenues in fields such as neurobiology, developmental biology, and oncology, among others. To date, we know that the RNA modification machinery finely tunes many diverse mechanisms involved in RNA processing and translation to regulate gene expression. However, it appears obvious to the research community that we have only just begun the process of understanding the several functions of the dynamic web of RNA modification, or the "epitranscriptome". To expand the data generated so far, recently published studies revealed a dual role for N6-methyladenosine (m6A), the most abundant mRNA modification, in driving both chromatin dynamics and transcriptional output. These studies showed that the m6A-modified, chromatin-associated RNAs could act as molecular docks, recruiting histone modification proteins and thus contributing to the regulation of local chromatin structure. Here, we review these latest exciting findings and outline outstanding research questions whose answers will help to elucidate the biological relevance of the m6A modification of chromatin-associated RNAs in mammalian cells.
Keywords: LLPS (Liquid–Liquid Phase Separation); N6-methyladenosine; chromatin; chromatin-associated RNAs; histone modifications; transcription; transposable elements.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.Exp Neurol. 2021 Nov;345:113829. doi: 10.1016/j.expneurol.2021.113829. Epub 2021 Jul 31. Exp Neurol. 2021. PMID: 34339678 Review.
-
Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.Stem Cells Dev. 2021 Jan 1;30(1):17-28. doi: 10.1089/scd.2020.0157. Epub 2020 Dec 21. Stem Cells Dev. 2021. PMID: 33231507 Review.
-
[Progress in epigenetic modification of mRNA and the function of m6A modification].Sheng Wu Gong Cheng Xue Bao. 2019 May 25;35(5):775-783. doi: 10.13345/j.cjb.180416. Sheng Wu Gong Cheng Xue Bao. 2019. PMID: 31222996 Review. Chinese.
-
The Role of N6-Methyladenosine (m6A) RNA Modification in the Pathogenesis of Parkinson's Disease.Biomolecules. 2025 Apr 23;15(5):617. doi: 10.3390/biom15050617. Biomolecules. 2025. PMID: 40427510 Free PMC article. Review.
-
N6-methyladenosine–encoded epitranscriptomics.Nat Struct Mol Biol. 2016 Feb;23(2):98-102. doi: 10.1038/nsmb.3162. Nat Struct Mol Biol. 2016. PMID: 26840897
Cited by
-
The Methylation Game: Epigenetic and Epitranscriptomic Dynamics of 5-Methylcytosine.Front Cell Dev Biol. 2022 Jun 3;10:915685. doi: 10.3389/fcell.2022.915685. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35721489 Free PMC article. Review.
-
Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.Int J Mol Sci. 2022 Jul 23;23(15):8122. doi: 10.3390/ijms23158122. Int J Mol Sci. 2022. PMID: 35897696 Free PMC article. Review.
-
Recent advances in the plant epitranscriptome.Genome Biol. 2023 Mar 7;24(1):43. doi: 10.1186/s13059-023-02872-6. Genome Biol. 2023. PMID: 36882788 Free PMC article. Review.
-
N‑methyladenosine reader YTHDF2‑mediated AC026691.1 degradation promotes gastric cancer cell proliferation, migration and M2 macrophage polarization.Mol Med Rep. 2025 May;31(5):120. doi: 10.3892/mmr.2025.13485. Epub 2025 Mar 7. Mol Med Rep. 2025. PMID: 40052573 Free PMC article.
-
Emerging Mutual Regulatory Roles between m6A Modification and microRNAs.Int J Mol Sci. 2023 Jan 1;24(1):773. doi: 10.3390/ijms24010773. Int J Mol Sci. 2023. PMID: 36614216 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources